FDA Clears Additional Indication for GT Medical’s Brain Tumor Therapy

January 30, 2020

The FDA granted clearance for an expanded indication for GT Medical’s GammaTile device, a surgically targeted radiation therapy.

The therapy can now be offered to patients who have newly diagnosed malignant brain tumors, as well as patients with recurrent brain tumors.

The device is used in patients following brain tumor removal to accelerate radiation treatment and help prevent tumor recurrence. It enables patients to receive their radiation treatment at home.

View today's stories